Barnett & Company Inc. lessened its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,434 shares of the company’s stock after selling 795 shares during the quarter. AbbVie accounts for 3.8% of […]
Legacy CG LLC purchased a new position in Accenture plc (NYSE:ACN – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,788 shares of the information technology services provider’s stock, valued at approximately $2,403,000. A number of other […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
AbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research decreased their Q3 2023 earnings per share estimates for shares of AbbVie in a research report issued on Thursday, October 19th. Zacks Research analyst S. Ganoria now forecasts that the company will earn $2.83 per share for the quarter, down from their prior forecast […]
Klingenstein Fields & Co. LP lowered its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,073 shares of the company’s stock after selling 85 shares during the quarter. Klingenstein […]